SonoScape Medical Corp. (300633.SZ)
CNY 30.8
(-1.91%)
CNY 30.8
(-1.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.47 Billion CNY | 24.87% |
| 2022 | 1.17 Billion CNY | 21.08% |
| 2021 | 973.39 Million CNY | 25.95% |
| 2020 | 772.81 Million CNY | -5.59% |
| 2019 | 818.57 Million CNY | -4.51% |
| 2018 | 857.25 Million CNY | 26.85% |
| 2017 | 675.77 Million CNY | 44.54% |
| 2016 | 467.53 Million CNY | 8.54% |
| 2015 | 430.75 Million CNY | 6.63% |
| 2014 | 403.95 Million CNY | 12.0% |
| 2013 | 360.67 Million CNY | 31.11% |
| 2012 | 275.1 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 328.3 Million CNY | -29.09% |
| 2024 Q2 | 350.18 Million CNY | 6.67% |
| 2024 Q3 | 248.15 Million CNY | -29.14% |
| 2023 Q4 | 462.95 Million CNY | 60.18% |
| 2023 FY | 1.47 Billion CNY | 24.87% |
| 2023 Q2 | 395.2 Million CNY | 21.79% |
| 2023 Q3 | 289.02 Million CNY | -26.87% |
| 2023 Q1 | 324.5 Million CNY | -12.01% |
| 2022 Q4 | 368.79 Million CNY | 39.21% |
| 2022 Q2 | 322.08 Million CNY | 44.55% |
| 2022 Q1 | 222.81 Million CNY | -36.98% |
| 2022 FY | 1.17 Billion CNY | 21.08% |
| 2022 Q3 | 264.91 Million CNY | -17.75% |
| 2021 FY | 973.39 Million CNY | 25.95% |
| 2021 Q1 | 175.31 Million CNY | -44.1% |
| 2021 Q2 | 246.27 Million CNY | 40.48% |
| 2021 Q4 | 353.56 Million CNY | 78.36% |
| 2021 Q3 | 198.23 Million CNY | -19.51% |
| 2020 Q4 | 313.61 Million CNY | 106.07% |
| 2020 Q3 | 152.19 Million CNY | -4.0% |
| 2020 Q2 | 158.53 Million CNY | 6.78% |
| 2020 Q1 | 148.47 Million CNY | -50.46% |
| 2020 FY | 772.81 Million CNY | -5.59% |
| 2019 FY | 818.57 Million CNY | -4.51% |
| 2019 Q4 | 299.69 Million CNY | 99.55% |
| 2019 Q2 | 216.67 Million CNY | 42.53% |
| 2019 Q1 | 152.02 Million CNY | -48.96% |
| 2019 Q3 | 150.18 Million CNY | -30.68% |
| 2018 Q3 | 185.89 Million CNY | -10.55% |
| 2018 Q4 | 297.87 Million CNY | 60.24% |
| 2018 FY | 857.25 Million CNY | 26.85% |
| 2018 Q1 | 165.67 Million CNY | -29.72% |
| 2018 Q2 | 207.81 Million CNY | 25.44% |
| 2017 Q3 | 148.64 Million CNY | -17.95% |
| 2017 Q1 | 110.22 Million CNY | -48.58% |
| 2017 FY | 675.77 Million CNY | 44.54% |
| 2017 Q2 | 181.17 Million CNY | 64.37% |
| 2017 Q4 | 235.72 Million CNY | 58.58% |
| 2016 Q2 | 102.51 Million CNY | 71.51% |
| 2016 FY | 467.53 Million CNY | 8.54% |
| 2016 Q4 | 214.35 Million CNY | 135.83% |
| 2016 Q3 | 90.89 Million CNY | -11.33% |
| 2016 Q1 | 59.76 Million CNY | 0.0% |
| 2015 Q1 | 85.05 Million CNY | 0.0% |
| 2015 FY | 430.75 Million CNY | 6.63% |
| 2014 FY | 403.95 Million CNY | 12.0% |
| 2013 FY | 360.67 Million CNY | 31.11% |
| 2012 FY | 275.1 Million CNY | 0.0% |